- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02487875
Sit-to-stand and Peripheral Muscle Strength in COPD
June 29, 2015 updated by: Andrea Zanini, Maugeri Foundation
The One Repetition Maximum Test and the Sit-to-stand Test in the Assessment of a Specific Pulmonary Rehabilitation Program on Peripheral Muscle Strength in COPD Patients
Background: Individuals with COPD may present reduced peripheral muscle strength, which leads to impaired mobility.
Comprehensive pulmonary rehabilitation (PR) should include strength training, in particular to lower limbs.
Furthermore, simple tools for the assessment of lower extremity muscles' performance are required.
Objectives: To assess the muscle strength of COPD patients by the sit-to-stand test (STST) as compared to the one-repetition maximum (1-RM), considered as the gold standard in non-laboratory situations, and to evaluate the responsiveness of STST to a PR program with specific strength training (SPR), compared to usual PR program (UPR).
Methods: 60 moderate-to-severe COPD inpatients were randomly included into either the SPR or into the UPR.
30-sec STST, 1-min STST, 1-RM and 6MWT were assessed before and after PRs.
Study Overview
Detailed Description
Background: Individuals with COPD may present reduced peripheral muscle strength, which leads to impaired mobility.
Comprehensive pulmonary rehabilitation (PR) should include strength training, in particular to lower limbs.
Furthermore, simple tools for the assessment of lower extremity muscles' performance are required.
Objectives: To assess the muscle strength of COPD patients by the sit-to-stand test (STST) as compared to the one-repetition maximum (1-RM), considered as the gold standard in non-laboratory situations, and to evaluate the responsiveness of STST to a PR program with specific strength training (SPR), compared to usual PR program (UPR).
Methods: 60 moderate-to-severe COPD inpatients were randomly included into either the SPR or into the UPR.
30-sec STST, 1-min STST, 1-RM and 6MWT were assessed before and after PRs.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
VA
-
Tradate, VA, Italy, 21049
- Fondazione Maugeri di Tradate
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 87 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- diagnosis for COPD according to the GOLD criteria.
- no exacerbations over the previous four weeks
- completing PR program
- smoking history ≥10 pack years
- regular treatment with inhaled bronchodilators and inhaled steroids
Exclusion Criteria:
- any unstable medical condition
- Contraindications for participation in the PR program included musculoskeletal disorders, malignant diseases, unstable cardiac condition, and lack of adherence to the program
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: COPD patients -study group
COPD inpatients GOLD2-4, in stable conditions,hospitalized to follow a pulmonary rehabilitation programme.
The study group performs in addition to the standard programme, also a peripheric muscle strength training
|
|
|
Active Comparator: COPD patients -control group
COPD inpatients GOLD2-4, in stable conditions,hospitalized to follow a pulmonary rehabilitation programme
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
evaluate the lower limbs' muscle strength by two STSTs (30-sec and 1-min), as compared to the 1-RM in patients with clinically stable COPD, both at baseline and after a PR with specific lower limbs' muscle strength training (SPR).
Time Frame: 1 month
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2014
Primary Completion (Actual)
April 1, 2015
Study Completion (Actual)
April 1, 2015
Study Registration Dates
First Submitted
June 25, 2015
First Submitted That Met QC Criteria
June 29, 2015
First Posted (Estimate)
July 2, 2015
Study Record Updates
Last Update Posted (Estimate)
July 2, 2015
Last Update Submitted That Met QC Criteria
June 29, 2015
Last Verified
June 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- Maugeri1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.